← Back to Search

REASSURE for Breast Cancer (REASSURE Trial)

N/A
Waitlist Available
Led By Heather Neuman, MD, MS, FACS
Research Sponsored by University of Wisconsin, Madison
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up up to 1 year
Awards & highlights

REASSURE Trial Summary

This study is evaluating whether a new approach to follow-up care for breast cancer survivors can reduce burden for survivors and their oncologists while simultaneously delivering more comprehensive care.

Eligible Conditions
  • Breast Cancer

REASSURE Trial Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~up to 1 year
This trial's timeline: 3 weeks for screening, Varies for treatment, and up to 1 year for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Feasibility: Number of Eligible Participants Enrolled
Number of PRO-generated Referral Recommendations that are Concordant with Medical Oncology Opinion
Number of Participants who Replace or are Eligible to Replace a Medical Oncology Follow-Up visit with Feedback Communication
+1 more
Secondary outcome measures
Knowledge about survivorship issues measured with the Preparing for Life as a (New) Survivor (PLANS) Scale
Number of Participants Whose Concerns Were Addressed During the Preceding Visit
Percent of Survivors Who Would Recommend this Approach to other survivors
+2 more
Other outcome measures
Impact of Event Scale Score
The Human Connection (THC) Scale Score

REASSURE Trial Design

2Treatment groups
Experimental Treatment
Group I: REASSURE Cohort 2Experimental Treatment1 Intervention
Survivors who are enrolled prior to a follow-up visit and who will be offered the REASSURE PRO assessment and feedback communication (but not provided the opportunity to replace a visit with feedback communication).
Group II: REASSURE Cohort 1Experimental Treatment1 Intervention
Survivors who are enrolled at time of a follow-up visit and who will be offered the REASSURE intervention at the next 6 month visit (including the opportunity to replace a visit with feedback communication).

Find a Location

Who is running the clinical trial?

University of Wisconsin, MadisonLead Sponsor
1,183 Previous Clinical Trials
3,167,557 Total Patients Enrolled
35 Trials studying Breast Cancer
38,489 Patients Enrolled for Breast Cancer
Heather Neuman, MD, MS, FACSPrincipal InvestigatorUniversity of Wisconsin, Madison

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Recent research and studies
clinicaltrials.govStudy
Remote Electronic Assessment of Survivors With Feedback Communication and Directed Referrals
2021. "Remote Electronic Assessment of Survivors With Feedback Communication and Directed Referrals". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT05047575.
~8 spots leftby Apr 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top